Christopher Brooke

Insider Reports History

Entity
Individual
Location
C/O Aytu Biopharma, Inc., 373 Inverness Parkway, Suite 206, Englewood, CO
Signature
/s/ Mark K. Oki as attorney-in-fact for Christopher Brooke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Brooke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AYTU BIOPHARMA, INC Chief Operating Officer Common Stock 1.17M $2.18M $1.87 Nov 15, 2022 Direct
AYTU BIOPHARMA, INC Chief Operating Officer Employee Stock Option (Right to Buy) 7K Aug 11, 2023 Direct

Insider Reports Filed by Christopher Brooke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AYTU AYTU BIOPHARMA, INC Aug 11, 2023 1 $0 4 Aug 15, 2023 Chief Operating Officer
AYTU AYTU BIOPHARMA, INC Nov 15, 2022 0 $0 3 Nov 15, 2022 Chief Operating Officer